Download PDF
J Neurol Surg A Cent Eur Neurosurg 2023; 84(03): 240-246
DOI: 10.1055/s-0042-1743552
Original Article

Effects of Methylprednisolone in the Treatment of Spinal Cord Injuries by Evaluation of microRNA-21: An Experimental Study

Anas Abdallah 
1   Department of Neurosurgery, Osmaniye State Hospital, Merkez–Osmaniye, Turkey
,
Abdurrahim Tekin 
2   Department of Neurosurgery, Istanbul Medipol University, Çamlıca Hospital, Üsküdar–Istanbul, Turkey
,
Mustafa Namik Oztanir 
3   Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey
,
Seda Süsgün 
4   Department of Medical Biology, Bezmialem Vakif University, Istanbul, Turkey
,
Ayşegül Yabacı 
5   Department of Biostatistics, Bezmialem Vakif University, Istanbul, Turkey
,
İrfan Çınar 
6   Department of Neurosurgery, Aile Hospital, Bahçelievler–Istanbul, Turkey
,
Engin Can 
3   Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey
,
Sadık Tokar 
3   Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey
,
Fahri Akbaş 
4   Department of Medical Biology, Bezmialem Vakif University, Istanbul, Turkey
,
Mehmet Hakan Seyithanoğlu 
3   Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Background and Study Aims Spinal cord injury (SCI) is one of the most complicated pathologies that affect active young males. miR-21 primarily regulates several cellular processes. We aimed to elucidate the regulatory role of miR-21 and test methylprednisolone as a disease-modifying agent on experimental SCI tissues.

Methods A total of 36 8- to 10-week-old adult female Sprague-Dawley rats weighing 250 to 300 g were used. Animals were randomly divided into six groups. Except for groups 1 and 4, the spinal trauma model was applied to all animal groups using the clipping method. In groups 3 and 6, methylprednisolone was given. For real-time polymerase chain reaction (PCR) investigations, rats in groups 1, 2, and 3 were reoperated on after the first postoperative day, whereas those in groups 4, 5, and 6 were reoperated on after postoperative day 7 and spinal cord samples from the laminectomy area were removed for gene expression analysis. Relative gene expression of miR-21, Gfap, Vim, Stat3, Faslg, Pten, Bax, Bcl2, Cox2, and Il6 were determined with quantitative reverse transcription (qRT) PCR.

Results In group 3, the miR-21 expression significantly increased compared with groups 1 and 2. When compared with group 3, a decrease in miR-21 expression was observed in group 6 (p < 0.05). When compared with group 4, group 6 had lower levels of Gfap, Pten, Stat3, and Bax (p < 0.05).

Conclusions miR-21 supports the beneficial aspects of the body's healing mechanisms following SCI. In the acute phase, the use of methylprednisolone increases miR-21 expression in the early period of trauma. Methylprednisolone increases some astrogliosis and inflammation biomarkers' levels; however, it did not affect the apoptotic biomarkers.

Keywords

spinal cord injury - miR-21 - methylprednisolone - real-time PCR

Author Contribution

Anas Abdallah** was responsible for conceptualization, methodology, software, supervision, formal analysis, statistical analysis, literature review, visualization, investigation, writing of the original draft and review of the draft, and validation. Abdurrahim Tekin** was responsible for conceptualization, supervision, methodology, literature review, writing and reviewing, visualization, investigation, and formal analysis of the manuscript. Mustafa Namik Oztanir and Seda Süsgün were responsible for validation and methodology. Seda Süsgün also participated in the investigation. Ayşegül Yabacı was responsible for statistical analysis. İrfan Çınar was responsible for validation, formal analysis, and literature review. Engin Can and Sadık Tokar participated in the validation of the study. Fahri Akbaş was also responsible for the methodology of the study. Mehmet Hakan Seyithanoğlu was responsible for supervision of the study.


**Drs. Tekin and Abdallah contributed equally in this work. Both of co-authors deserve the first name.




Publication History

Received: 23 March 2021

Accepted: 15 September 2021

Article published online:
19 April 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Singh A, Tetreault L, Kalsi-Ryan S, Nouri A, Fehlings MG. Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol 2014; 6: 309-331
    PubMedGoogle Scholar
  • 2 Lee BB, Cripps RA, Fitzharris M, Wing PC. The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate. Spinal Cord 2014; 52 (02) 110-116
    CrossrefPubMedGoogle Scholar
  • 3 Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36 (Database issue): D154-D158
    CrossrefPubMedGoogle Scholar
  • 4 Jiang Y, Zhao S, Ding Y. et al. MicroRNA–21 promotes neurite outgrowth by regulating PDCD4 in a rat model of spinal cord injury. Mol Med Rep 2017; 16 (03) 2522-2528
    CrossrefPubMedGoogle Scholar
  • 5 Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11 (04) 441-450
    CrossrefPubMedGoogle Scholar
  • 6 Talotta F, Cimmino A, Matarazzo MR. et al. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 2009; 28 (01) 73-84
    CrossrefPubMedGoogle Scholar
  • 7 Redell JB, Zhao J, Dash PK. Altered expression of miRNA-21 and its targets in the hippocampus after traumatic brain injury. J Neurosci Res 2011; 89 (02) 212-221
    CrossrefPubMedGoogle Scholar
  • 8 Lei P, Li Y, Chen X, Yang S, Zhang J. Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury. Brain Res 2009; 1284: 191-201
    CrossrefPubMedGoogle Scholar
  • 9 Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65 (14) 6029-6033
    CrossrefPubMedGoogle Scholar
  • 10 Evaniew N, Belley-Côté EP, Fallah N, Noonan VK, Rivers CS, Dvorak MF. Methylprednisolone for the treatment of patients with acute spinal cord injuries: a systematic review and meta-analysis. J Neurotrauma 2016; 33 (05) 468-481
    CrossrefPubMedGoogle Scholar
  • 11 Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008; 209 (02) 378-388
    CrossrefPubMedGoogle Scholar
  • 12 Põlajeva J, Swartling FJ, Jiang Y. et al. miRNA-21 is developmentally regulated in mouse brain and is co-expressed with SOX2 in glioma. BMC Cancer 2012; 12: 378
    CrossrefPubMedGoogle Scholar
  • 13 Abdallah A. Correlation of hydromyelia with subarachnoid hemorrhage-related hydrocephalus: an experimental study. Neurosurg Rev 2021; 44 (03) 1437-1445
    CrossrefPubMedGoogle Scholar
  • 14 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25 (04) 402-408
    CrossrefPubMedGoogle Scholar
  • 15 Liu Z, Yang Y, He L. et al. High-dose methylprednisolone for acute traumatic spinal cord injury: A meta-analysis. Neurology 2019; 93 (09) e841-e850
    CrossrefPubMedGoogle Scholar
  • 16 Hugenholtz H, Cass DE, Dvorak MF. et al. High-dose methylprednisolone for acute closed spinal cord injury: only a treatment option. Can J Neurol Sci 2002; 29 (03) 227-235
    CrossrefPubMedGoogle Scholar
  • 17 Qian T, Guo X, Levi AD, Vanni S, Shebert RT, Sipski ML. High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord 2005; 43 (04) 199-203
    CrossrefPubMedGoogle Scholar
  • 18 Ito Y, Sugimoto Y, Tomioka M, Kai N, Tanaka M. Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury?: a prospective study about neurological recovery and early complications. Spine 2009; 34 (20) 2121-2124
    CrossrefPubMedGoogle Scholar
  • 19 Chen G, Zhang Z, Wang S, Lv D. Combined treatment with FK506 and nerve growth factor for spinal cord injury in rats. Exp Ther Med 2013; 6 (04) 868-872
    CrossrefPubMedGoogle Scholar
  • 20 Ilhan A, Akyol O, Gurel A, Armutcu F, Iraz M, Oztas E. Protective effects of caffeic acid phenethyl ester against experimental allergic encephalomyelitis-induced oxidative stress in rats. Free Radic Biol Med 2004; 37 (03) 386-394
    CrossrefPubMedGoogle Scholar
  • 21 Karimi-Abdolrezaee S, Billakanti R. Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. Mol Neurobiol 2012; 46 (02) 251-264
    CrossrefPubMedGoogle Scholar
  • 22 Dong J, Lu M, He X. et al. Identifying the role of microRNAs in spinal cord injury. Neurol Sci 2014; 35 (11) 1663-1671
    CrossrefPubMedGoogle Scholar
  • 23 Hu JZ, Huang JH, Zeng L, Wang G, Cao M, Lu HB. Anti-apoptotic effect of microRNA-21 after contusion spinal cord injury in rats. J Neurotrauma 2013; 30 (15) 1349-1360
    CrossrefPubMedGoogle Scholar
  • 24 Martirosyan NL, Carotenuto A, Patel AA. et al. The role of microRNA markers in the diagnosis, treatment, and outcome prediction of spinal cord injury. Front Surg 2016; 3: 56
    CrossrefPubMedGoogle Scholar
  • 25 Jiao G, Pan B, Zhou Z, Zhou L, Li Z, Zhang Z. MicroRNA-21 regulates cell proliferation and apoptosis in H2O2-stimulated rat spinal cord neurons. Mol Med Rep 2015; 12 (05) 7011-7016
    CrossrefPubMedGoogle Scholar
  • 26 Liu D, Huang Y, Jia C, Li Y, Liang F, Fu Q. Administration of antagomir-223 inhibits apoptosis, promotes angiogenesis and functional recovery in rats with spinal cord injury. Cell Mol Neurobiol 2015; 35 (04) 483-491
    CrossrefPubMedGoogle Scholar
  • 27 Liu NK, Wang XF, Lu QB, Xu XM. Altered microRNA expression following traumatic spinal cord injury. Exp Neurol 2009; 219 (02) 424-429
    CrossrefPubMedGoogle Scholar
  • 28 Liu G, Keeler BE, Zhukareva V, Houlé JD. Cycling exercise affects the expression of apoptosis-associated microRNAs after spinal cord injury in rats. Exp Neurol 2010; 226 (01) 200-206
    CrossrefPubMedGoogle Scholar
  • 29 Alam MM, O'Neill LA. MicroRNAs and the resolution phase of inflammation in macrophages. Eur J Immunol 2011; 41 (09) 2482-2485
    CrossrefPubMedGoogle Scholar